GMP Consultant in Saudi Arabia for SFDA Readiness
Serving pharmaceutical manufacturers across Saudi Arabia, PHARPRO provides CSV validation, QA gap assessments, CQV, thermal mapping and GMP training structured around SFDA inspection expectations, available on-site or remotely.
Understanding the KSA Pharmaceutical Landscape
Saudi Arabia has one of the largest pharmaceutical markets in the Middle East, driven by Vision 2030 healthcare investments and an expanding domestic manufacturing base. The Saudi Food and Drug Authority (SFDA) applies rigorous GMP inspection standards closely aligned with EU GMP and PIC/S, with an increasing focus on data integrity, CSV, and quality system maturity.
PHARPRO's founder has Saudi pharmaceutical site-establishment experience from his employment with MS Pharma. PHARPRO now offers founder-led CSV, QA, CQV and GMP training support to KSA organisations remotely and, when agreed, on-site.
Compliance Services for KSA Pharma
Remote and on-site support, delivered at the pace your programme requires.
CSV Validation
Full-lifecycle CSV for pharma software and laboratory systems. IQ/OQ/PQ, URS, risk classification, and audit trail review - aligned with EU GMP Annex 11 and FDA 21 CFR Part 11.
QA & Gap Assessment
Gap assessments against Saudi Food & Drug Authority (SFDA) and international GMP standards. SOP reviews, CAPA management, and data integrity programmes.
CQV & Thermal Mapping
Equipment and utility qualification (IQ/OQ/PQ) and temperature mapping studies for KSA pharmaceutical warehouses, cold chain facilities, and manufacturing areas.
GMP Training
Customised GMP training for KSA pharma teams - data integrity, CSV fundamentals, IQ/OQ/PQ methodology, and inspection readiness.
Inspection Readiness
Mock audits and gap assessments to prepare your KSA site for Saudi Food & Drug Authority (SFDA) inspections and international authority audits.
CAPA Management
Root cause analysis, corrective and preventive action planning, and CAPA effectiveness checks - aligned with ICH Q10 and GMP requirements.
Regulations We Work Within in KSA
All PHARPRO work in Kingdom of Saudi Arabia is aligned with applicable local and international regulatory standards.
Frequently Asked Questions - KSA
Yes. PHARPRO accepts remote and on-site KSA engagements. The founder's Saudi experience was gained while employed by MS Pharma and is not counted as a PHARPRO client project.
Pharmaceutical companies in Kingdom of Saudi Arabia must comply with Saudi Food & Drug Authority (SFDA) requirements, closely aligned with SFDA GMP Guidelines, SFDA Drug Sector Regulatory Requirements, and PIC/S GMP Guidelines. Export-focused manufacturers must additionally comply with the regulatory requirements of their target markets.
Remote delivery works well for most Saudi engagements — documentation, gap analysis and training don't require an on-site presence. For thermal mapping, facility walkthroughs or mock inspections, Mohammad travels to the client site as needed.
For time-sensitive situations — an upcoming SFDA inspection or a regulatory finding — remote work can begin within 3-5 business days. Scheduled Saudi engagements usually start 1-2 weeks after agreeing the proposal.
Ready to start your KSA compliance project?
Start with a free 30-minute compliance assessment. No commitment, no sales pitch.
الخدمات في السعودية